Is the angiotensin receptor blocker cancer risk overstated?

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1351, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin receptor antagonists lower cancer risk?

Reactions Weekly, Vol. 1, Iss. 1345, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Are medical error deaths overstated in IOM report?

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

The angiotensin receptor blocker valsartan is as effective in reducing the risk of atherosclerotic events as captopril

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

By Tedesco M.A. Ratti G. Di Salvo G. Natale F.

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Be Used Safely in Patients with Previous ACE Inhibitor-Induced Angioedema?

By Howes L.G.

Drug Safety, Vol. 25, Iss. 2, 2002-01 ,pp. : 73-76

Adis International

Access to resources Recommend Favorite